AVBP Cash & Short-Term Investments

Arrivent Biopharma Inc · Cash & Short-Term Investments

AVBP logo

AVBP Cash & Short-Term Investments

Latest reported$312.82M
AVBP FY Cash & Short-Term Investments ($37.28M → $312.82M)
High-resolution chart · PNG

AVBP cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arrivent Biopharma Inc Cash & Short-Term Investments — Annual fiscal periods (USD)
Period endingCash & Short-Term Investments (USD)
312,821,000
218,863,000
150,389,000
163,372,000
37,280,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.